Zimmer Biomet Holdings, Inc. (ZBH) EV/FCF Ratio: 13.22x
Is Zimmer Biomet Holdings, Inc.’s EV/FCF ratio high or low?
Zimmer Biomet Holdings, Inc.'s EV/FCF ratio of 13.22x is 47% below its 5-year average of 24.85x, near the low end of its 5-year range (12.33x–45.78x).
As of Saturday, June 20, 2026. 17.62% below its 12-month average of 16.05x.
ZBH EV/FCF Ratio Chart
ZBH Average EV/FCF Ratio Chart
ZBH Current vs Average EV/FCF Ratio Chart
ZBH EV/FCF Ratio Metrics
EV/FCF RATIO
13.22x
EV/FCF RATIO AVG TTM
16.05x
EV/FCF RATIO AVG 3Y
23.18x
EV/FCF RATIO AVG 5Y
24.54x
EV/FCF RATIO AVG 10Y
25.33x
EV/FCF RATIO AVG 15Y
22.95x
EV/FCF RATIO AVG 20Y
22.01x
CURRENT VS TTM AVG
-17.62%
CURRENT VS 3Y AVG
-42.96%
CURRENT VS 5Y AVG
-46.13%
CURRENT VS 10Y AVG
-47.81%
CURRENT VS 15Y AVG
-42.40%
CURRENT VS 20Y AVG
-39.93%
ZBH Competitors' EV/FCF Ratio
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zimmer Biomet Holdings, Inc. (ZBH) | $17.02B | 13.22x | 16.05x | 23.18x | 24.54x |
| Hologic, Inc. (HOLX)vs › | $16.97B | 17.53x | 16.94x | 18.67x | 15.16x |
| DaVita Inc. (DVA)vs › | $13.34B | 17.96x | 17.77x | 17.75x | 18.16x |
| Medpace Holdings, Inc. (MEDP)vs › | $13.14B | 17.35x | 21.71x | 22.24x | 22.57x |
| Solventum Corporation (SOLV)vs › | $13.06B | N/A | 157.09x | 88.54x | 88.54x |
| Labcorp Holdings Inc. (LH)vs › | $20.98B | 19.85x | 22.30x | 25.43x | 20.42x |
| Align Technology, Inc. (ALGN)vs › | $13.04B | 17.63x | 17.66x | 29.34x | 38.73x |
| The Cooper Companies, Inc. (COO)vs › | $12.85B | 26.64x | 39.51x | 81.61x | 66.06x |
| United Therapeutics Corporation (UTHR)vs › | $22.78B | 23.85x | 18.99x | 17.01x | 17.02x |
| Revvity, Inc. (RVTY)vs › | $11.16B | 27.69x | 26.79x | 265.50x | 164.11x |
Cash Flow Valuation Comparison
EV/FCF
13.2x
P/FCF
9.4x
FCF Yield
10.66%
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
- EV/FCF accounts for debt and cash through enterprise value
- P/FCF only considers equity value
- EV/FCF can be compared across companies with different debt levels
- Both measure how the market values cash generation
Zimmer Biomet Holdings, Inc. EV/FCF Ratio Formula & Definition
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Zimmer Biomet Holdings, Inc. EV/FCF Ratio FAQ
- What is the EV/FCF ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
- The EV/FCF ratio for ZBH stock is 13.22x.
- Is Zimmer Biomet Holdings, Inc.'s EV/FCF ratio high or low?
- Zimmer Biomet Holdings, Inc.'s EV/FCF ratio of 13.22x is 47% below its 5-year average of 24.85x, near the low end of its 5-year range (12.33x–45.78x).
- What is the TTM average EV/FCF ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
- The TTM average EV/FCF ratio for ZBH stock is 16.05x.
- What is the 3Y average EV/FCF ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
- The 3Y average EV/FCF ratio for ZBH stock is 23.18x.
- What is the 5Y average EV/FCF ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
- The 5Y average EV/FCF ratio for ZBH stock is 24.54x.
- What is the 10Y average EV/FCF ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
- The 10Y average EV/FCF ratio for ZBH stock is 25.33x.
- What is the 15Y average EV/FCF ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
- The 15Y average EV/FCF ratio for ZBH stock is 22.95x.
- What is the 20Y average EV/FCF ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
- The 20Y average EV/FCF ratio for ZBH stock is 22.01x.
Zimmer Biomet Holdings, Inc. EV/FCF Ratio History
| DATE | EV/FCF RATIO |
|---|---|
| 2026-06-18 | 13.22x |
| 2026-06-17 | 13.14x |
| 2026-06-16 | 13.37x |
| 2026-06-15 | 13.25x |
| 2026-06-12 | 13.29x |
| 2026-06-11 | 13.13x |
| 2026-06-10 | 13.24x |
| 2026-06-09 | 13.40x |
| 2026-06-08 | 13.15x |
| 2026-06-05 | 13.16x |
| 2026-06-04 | 13.09x |
| 2026-06-03 | 12.90x |
| 2026-06-02 | 12.77x |
| 2026-06-01 | 12.69x |
| 2026-05-29 | 12.62x |
| 2026-05-28 | 12.67x |
| 2026-05-27 | 12.65x |
| 2026-05-26 | 12.84x |
| 2026-05-22 | 12.96x |
| 2026-05-21 | 12.94x |
| 2026-05-20 | 12.95x |
| 2026-05-19 | 13.02x |
| 2026-05-18 | 12.92x |
| 2026-05-15 | 12.77x |
| 2026-05-14 | 12.66x |
| 2026-05-13 | 12.66x |
| 2026-05-12 | 12.73x |
| 2026-05-11 | 12.33x |
| 2026-05-08 | 12.62x |
| 2026-05-07 | 12.73x |
| 2026-05-06 | 12.67x |
| 2026-05-05 | 12.69x |
| 2026-05-04 | 12.66x |
| 2026-05-01 | 12.68x |
| 2026-04-30 | 12.58x |
| 2026-04-29 | 12.33x |
| 2026-04-28 | 12.62x |
| 2026-04-27 | 13.67x |
| 2026-04-24 | 13.53x |
| 2026-04-23 | 13.65x |
| 2026-04-22 | 13.72x |
| 2026-04-21 | 13.68x |
| 2026-04-20 | 13.98x |
| 2026-04-17 | 13.91x |
| 2026-04-16 | 13.91x |
| 2026-04-15 | 13.84x |
| 2026-04-14 | 14.09x |
| 2026-04-13 | 13.97x |
| 2026-04-10 | 13.73x |
| 2026-04-09 | 13.72x |
| 2026-04-08 | 13.72x |
| 2026-04-07 | 13.54x |
| 2026-04-06 | 13.50x |
| 2026-04-02 | 13.49x |
| 2026-04-01 | 13.50x |
| 2026-03-31 | 13.44x |
| 2026-03-30 | 13.25x |
| 2026-03-27 | 13.24x |
| 2026-03-26 | 13.30x |
| 2026-03-25 | 13.14x |
| 2026-03-24 | 13.00x |
| 2026-03-23 | 13.16x |
| 2026-03-20 | 13.17x |
| 2026-03-19 | 13.38x |
| 2026-03-18 | 13.29x |
| 2026-03-17 | 13.66x |
| 2026-03-16 | 13.75x |
| 2026-03-13 | 13.74x |
| 2026-03-12 | 13.68x |
| 2026-03-11 | 13.79x |
| 2026-03-10 | 13.58x |
| 2026-03-09 | 13.74x |
| 2026-03-06 | 13.83x |
| 2026-03-05 | 13.76x |
| 2026-03-04 | 14.01x |
| 2026-03-03 | 14.25x |
| 2026-03-02 | 14.41x |
| 2026-02-27 | 14.30x |
| 2026-02-26 | 14.57x |
| 2026-02-25 | 14.45x |
| 2026-02-24 | 14.45x |
| 2026-02-23 | 14.41x |
| 2026-02-20 | 14.33x |
| 2026-02-19 | 14.38x |
| 2026-02-18 | 16.46x |
| 2026-02-17 | 16.32x |
| 2026-02-13 | 16.24x |
| 2026-02-12 | 16.08x |
| 2026-02-11 | 16.13x |
| 2026-02-10 | 15.61x |
| 2026-02-09 | 15.40x |
| 2026-02-06 | 15.42x |
| 2026-02-05 | 15.28x |
| 2026-02-04 | 15.20x |
| 2026-02-03 | 14.96x |
| 2026-02-02 | 14.96x |
| 2026-01-30 | 15.07x |
| 2026-01-29 | 14.94x |
| 2026-01-28 | 14.90x |
| 2026-01-27 | 14.94x |
| 2026-01-26 | 15.10x |
| 2026-01-23 | 15.01x |
| 2026-01-22 | 15.13x |
| 2026-01-21 | 15.01x |
| 2026-01-20 | 15.04x |
| 2026-01-16 | 15.10x |
| 2026-01-15 | 15.28x |
| 2026-01-14 | 15.34x |
| 2026-01-13 | 15.23x |
| 2026-01-12 | 15.61x |
| 2026-01-09 | 15.79x |
| 2026-01-08 | 15.94x |
| 2026-01-07 | 15.77x |
| 2026-01-06 | 16.02x |
| 2026-01-05 | 15.76x |
| 2026-01-02 | 15.44x |
| 2025-12-31 | 15.42x |
| 2025-12-30 | 15.53x |
| 2025-12-29 | 15.50x |
| 2025-12-26 | 15.53x |
| 2025-12-24 | 15.46x |
| 2025-12-23 | 15.36x |
| 2025-12-22 | 15.41x |
| 2025-12-19 | 15.33x |
| 2025-12-18 | 15.48x |
| 2025-12-17 | 15.63x |
| 2025-12-16 | 15.55x |
| 2025-12-15 | 15.74x |
| 2025-12-12 | 15.63x |
| 2025-12-11 | 15.74x |
| 2025-12-10 | 15.82x |
| 2025-12-09 | 15.72x |
| 2025-12-08 | 15.78x |
| 2025-12-05 | 15.97x |
| 2025-12-04 | 15.83x |
| 2025-12-03 | 15.82x |
| 2025-12-02 | 15.95x |
| 2025-12-01 | 16.03x |
| 2025-11-28 | 16.37x |
| 2025-11-26 | 16.37x |
| 2025-11-25 | 16.31x |
| 2025-11-24 | 15.87x |
| 2025-11-21 | 15.71x |
| 2025-11-20 | 15.32x |
| 2025-11-19 | 15.37x |
| 2025-11-18 | 15.32x |
| 2025-11-17 | 15.27x |
| 2025-11-14 | 15.42x |
| 2025-11-13 | 15.51x |
| 2025-11-12 | 15.44x |
| 2025-11-11 | 15.25x |
| 2025-11-10 | 15.28x |
| 2025-11-07 | 15.25x |
| 2025-11-06 | 15.25x |
| 2025-11-05 | 15.13x |
| 2025-11-04 | 19.30x |
| 2025-11-03 | 18.84x |
| 2025-10-31 | 18.93x |
| 2025-10-30 | 18.79x |
| 2025-10-29 | 18.81x |
| 2025-10-28 | 19.01x |
| 2025-10-27 | 19.29x |
| 2025-10-24 | 19.28x |
| 2025-10-23 | 19.29x |
| 2025-10-22 | 19.41x |
| 2025-10-21 | 19.23x |
| 2025-10-20 | 19.24x |
| 2025-10-17 | 19.12x |
| 2025-10-16 | 18.84x |
| 2025-10-15 | 18.77x |
| 2025-10-14 | 18.63x |
| 2025-10-13 | 18.17x |
| 2025-10-10 | 18.12x |
| 2025-10-09 | 18.49x |
| 2025-10-08 | 18.63x |
| 2025-10-07 | 18.72x |
| 2025-10-06 | 18.69x |
| 2025-10-03 | 18.96x |
| 2025-10-02 | 18.74x |
| 2025-10-01 | 18.70x |
| 2025-09-30 | 18.64x |
| 2025-09-29 | 18.61x |
| 2025-09-26 | 18.61x |
| 2025-09-25 | 18.43x |
| 2025-09-24 | 18.71x |
| 2025-09-23 | 18.89x |
| 2025-09-22 | 19.10x |
| 2025-09-19 | 18.87x |
| 2025-09-18 | 18.88x |
| 2025-09-17 | 18.84x |
| 2025-09-16 | 18.73x |
| 2025-09-15 | 18.99x |
| 2025-09-12 | 19.28x |
| 2025-09-11 | 19.45x |
| 2025-09-10 | 19.17x |
| 2025-09-09 | 19.39x |
| 2025-09-08 | 19.51x |
| 2025-09-05 | 19.65x |
| 2025-09-04 | 19.52x |
| 2025-09-03 | 19.56x |
| 2025-09-02 | 19.55x |
| 2025-08-29 | 19.70x |
| 2025-08-28 | 19.56x |
| 2025-08-27 | 19.80x |
| 2025-08-26 | 19.90x |
| 2025-08-25 | 19.87x |
| 2025-08-22 | 19.93x |
| 2025-08-21 | 19.47x |
| 2025-08-20 | 19.65x |
| 2025-08-19 | 19.45x |
| 2025-08-18 | 19.21x |
| 2025-08-15 | 19.24x |
| 2025-08-14 | 19.15x |
| 2025-08-13 | 19.30x |
| 2025-08-12 | 19.11x |
| 2025-08-11 | 18.86x |
| 2025-08-08 | 18.75x |
| 2025-08-07 | 18.63x |
| 2025-08-06 | 17.79x |
| 2025-08-05 | 17.92x |
| 2025-08-04 | 17.97x |
| 2025-08-01 | 17.71x |
| 2025-07-31 | 17.86x |
| 2025-07-30 | 18.11x |
| 2025-07-29 | 18.35x |
| 2025-07-28 | 18.50x |
| 2025-07-25 | 18.74x |
| 2025-07-24 | 18.64x |
| 2025-07-23 | 18.70x |
| 2025-07-22 | 18.58x |
| 2025-07-21 | 18.00x |
| 2025-07-18 | 18.09x |
| 2025-07-17 | 18.34x |
| 2025-07-16 | 18.24x |
| 2025-07-15 | 18.22x |
| 2025-07-14 | 18.19x |
| 2025-07-11 | 18.18x |
| 2025-07-10 | 18.38x |
| 2025-07-09 | 18.39x |
| 2025-07-08 | 18.13x |
| 2025-07-07 | 18.00x |
| 2025-07-03 | 18.16x |
| 2025-07-02 | 18.14x |
| 2025-07-01 | 18.22x |
| 2025-06-30 | 17.80x |
| 2025-06-27 | 17.84x |
| 2025-06-26 | 17.88x |
| 2025-06-25 | 18.03x |
| 2025-06-24 | 17.97x |
| 2025-06-23 | 17.84x |
| 2025-06-20 | 17.80x |
| 2025-06-18 | 17.70x |
| 2025-06-17 | 17.65x |
| 2025-06-16 | 17.94x |
| 2025-06-13 | 17.81x |
| 2025-06-12 | 18.10x |
| 2025-06-11 | 18.25x |
| 2025-06-10 | 18.35x |
| 2025-06-09 | 18.04x |
| 2025-06-06 | 17.97x |
Showing the most recent 260 of 5,032 data points. The chart above shows the full history.
Related Metrics
About Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. (ZBH), along with its global subsidiaries, operates as a leading player in the musculoskeletal healthcare sector. The company extends its reach across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. ZBH is responsible for the design, manufacturing, and marketing of a wide array of orthopedic reconstructive solutions, including prominent knee and hip replacement systems. Their offerings also encompass Specialized Enabling Technologies (S.E.T.) products, which cover areas such as sports medicine, biologics, foot and ankle care, extremity treatments, and trauma management. Furthermore, the company provides medical devices and surgical instruments specifically for spinal conditions, alongside products for facial and cranial reconstruction. A unique part of their portfolio includes systems designed to stabilize and fixate chest bones, facilitating recovery or reconstruction following open-heart surgery, traumatic injuries, or congenital chest deformities. The company's product lines also feature a comprehensive range of dental solutions, such as reconstructive implants, prosthetics, and regenerative materials. Additionally, they are involved in robotic surgical systems, general surgical instruments, and bone cements. These advanced products and solutions are primarily utilized to address conditions in patients suffering from disorders or injuries affecting bones, joints, and their associated soft tissues. Zimmer Biomet caters to a broad clientele, including orthopedic, neuro-, and oral surgeons, dentists, hospitals, independent distributors, healthcare suppliers, and various other medical specialists. Their network further encompasses agents, healthcare purchasing organizations, and group buying alliances. Originally established in 1927, the enterprise was initially known as Zimmer Holdings, Inc., before rebranding as Zimmer Biomet Holdings, Inc. in June 2015. Its corporate headquarters are situated in Warsaw, Indiana.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ivan Tornos